價(jià)格 | ¥10600 | ¥17500 | ¥13800 |
包裝 | 25mg | 100mg | 50mg |
最小起訂量 | 1mg |
發(fā)貨地 | 上海 |
更新日期 | 2025-02-14 |
中文名稱:化合物 Oxaprozin potassium | 英文名稱:Oxaprozin potassium |
CAS:174064-08-5 | 品牌: TargetMol |
產(chǎn)地: 美國(guó) | 保存條件: Shipping with blue ice. |
產(chǎn)品類別: 抑制劑 | |
貨號(hào): T60979 |
Name | Oxaprozin potassium |
Description | Oxaprozin potassium is an orally active and potent inhibitor of COX, with IC 50 values of 2.2 μM and 36 μM for human platelet COX-1 and for IL-1-stimulated human synovial cell COX-2, respectively. Oxaprozin potassium induces cell apoptosis. Oxaprozin potassium also inhibits the NF-κB activation. Oxaprozin potassium-mediated inhibition of the Akt/IKK/NF-κB pathway contributes to its anti-inflammatory properties [1] [2]. |
In vitro | Oxaprozin (0-100 μM) induces apoptosis in a dose-dependent manner. Oxaprozin increases caspase-3 activity in the activated but not in the resting condition. NF-κB activation is inhibited by Oxaprozin (50 μM). Oxaprozin inhibits activation of the IKK system induced by the reagent IκBα [1]. Oxaprozin (100 μM) induces the strongest proapoptotic effect and significantly increases CD40L-treated monocyte apoptosis. Oxaprozin treatment inhibits CD40L-induced Akt and NF-κB (p65) phosphorylation [2]. |
Storage | Shipping with blue ice. |
成立日期 | 2013-04-18 (12年) | 注冊(cè)資本 | 589.8595萬人民幣 |
員工人數(shù) | 100-500人 | 年?duì)I業(yè)額 | ¥ 1億以上 |
主營(yíng)行業(yè) | 中間體,天然產(chǎn)物,生物化工,化學(xué)試劑,生物技術(shù)服務(wù) | 經(jīng)營(yíng)模式 | 貿(mào)易,工廠,試劑,定制,服務(wù) |
產(chǎn)品名稱 | 價(jià)格 | 公司名稱 | 報(bào)價(jià)日期 | |
---|---|---|---|---|
詢價(jià) |
VIP10年
|
上海升德醫(yī)藥科技有限公司
|
2025-01-03 | |
詢價(jià) |
VIP3年
|
陜西締都新材料有限公司
|
2024-12-18 | |
詢價(jià) |
VIP3年
|
上海嘉定區(qū)澄瀏公路52號(hào)
|
2025-02-26 |